These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29324343)

  • 1. Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties.
    Capilla AS; Soucek R; Grau L; Romero M; Rubio-Martínez J; Caignard DH; Pujol MD
    Eur J Med Chem; 2018 Feb; 145():51-63. PubMed ID: 29324343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
    Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
    Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
    Gangapuram M; Eyunni S; Zhang W; Redda KK
    Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion.
    Hao C; Li X; Song S; Guo B; Guo J; Zhang J; Zhang Q; Huang W; Wang J; Lin B; Cheng M; Li F; Zhao D
    Org Biomol Chem; 2016 Aug; 14(32):7676-90. PubMed ID: 27454186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of new Myo-inositol derivatives as potential RAS inhibitors.
    Hussain J; Chhabria D; Kirubakaran S
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127290. PubMed ID: 32631512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives.
    Pang C; Zhao J; Zhang S; Chen J; Zeng X; Li H
    Bioorg Med Chem Lett; 2024 Sep; 109():129824. PubMed ID: 38823729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
    Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions.
    Zhang Y; Meng X; Tang H; Cheng M; Yang F; Xu W
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):344-353. PubMed ID: 31851852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
    Niida A; Sasaki S; Yonemori K; Sameshima T; Yaguchi M; Asami T; Sakamoto K; Kamaura M
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2757-2761. PubMed ID: 28457754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.
    Lu C; Tang K; Li Y; Li P; Lin Z; Yin D; Chen X; Huang H
    Eur J Med Chem; 2014 Apr; 77():351-60. PubMed ID: 24675135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors.
    Sun Y; Shan Y; Li C; Si R; Pan X; Wang B; Zhang J
    Eur J Med Chem; 2017 Dec; 141():373-385. PubMed ID: 29032031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors.
    Zhang JQ; Luo YJ; Xiong YS; Yu Y; Tu ZC; Long ZJ; Lai XJ; Chen HX; Luo Y; Weng J; Lu G
    J Med Chem; 2016 Aug; 59(15):7268-74. PubMed ID: 27427973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors.
    Elsayed MS; El-Araby ME; Serya RA; El-Khatib AH; Linscheid MW; Abouzid KA
    Eur J Med Chem; 2013 Mar; 61():122-31. PubMed ID: 23063746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4.
    Li C; Shan Y; Sun Y; Si R; Liang L; Pan X; Wang B; Zhang J
    Eur J Med Chem; 2017 Dec; 141():506-518. PubMed ID: 29102175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
    Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
    J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
    Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
    Song S; Li X; Guo J; Hao C; Feng Y; Guo B; Liu T; Zhang Q; Zhang Z; Li R; Wang J; Lin B; Li F; Zhao D; Cheng M
    Org Biomol Chem; 2015 Mar; 13(12):3803-18. PubMed ID: 25705811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.